Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680511 · ClinicalTrials.gov registry record · Phase 1
Development of a Family-Based Treatment for Adolescent Methamphetamine Use
A Phase 1 study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT00680511 is a Phase 1 study that has completed, run by Oregon Research Institute. The registered enrollment target is 60 participants.
The verdict
NCT00680511, a Phase 1 study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The AIMS study compares a methamphetamine-specific treatment intervention to a treatment-as-usual Functional Family Therapy (FFT) approach for adolescents ages 15 to 19. Adolescents are assigned to one of two treatment conditions: (1) 16 weeks of FFT designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use; or (2) 16 weeks of a combination of FFT and a methamphetamine-specific intervention involving group and individual therapy sessions; Families are assessed using questionnaires and interviews, and adolescents participate in neuropsychological testing, before, during, and after treatment to provide information about family functioning, the adolescent's drug use, the adolescent's peers, and other factors that may contribute to treatment success. Adolescents also provide urine specimens for drug screening at assessment visits. Through a partnership with Oregon Health and Science University (OHSU), adolescents will participate in functional magnetic resonance imaging appointments at the hospital to examine regional brain blood flow during tasks designed to measure impulsivity and risk-taking behaviors. As a treatment development grant, study investigators will study adolescents' acceptance of and response to the newly developed methamphetamine-specific treatment approach.
Interventions
- BEHAVIORAL Adolescent Methamphetamine Treament (AMT)
- BEHAVIORAL Functional Family Therapy (FFT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680511
The ClinicalTrials.gov registry entry for NCT00680511 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adolescent Methamphetamine Treament (AMT) is the first listed.
NCT00680511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680511 about?
NCT00680511 is a clinical study titled "Development of a Family-Based Treatment for Adolescent Methamphetamine Use". The AIMS study compares a methamphetamine-specific treatment intervention to a treatment-as-usual Functional Family Therapy (FFT) approach for adolescents ages 15 to 19. Adolescents are assigned to one of two treatment conditions: (1) 16 weeks of FFT designed to strengthen family relationships and d...
What is the current status of trial NCT00680511?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2007-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00680511?
The interventions under investigation include: Adolescent Methamphetamine Treament (AMT) (BEHAVIORAL), Functional Family Therapy (FFT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00680511?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.